ArticleMediterranean journal of hematology and infectious diseases2025

Dose-Attenuated-Polatuzumab Vedotine plus CHP vs. Dose-Attenuated -R-CHOP in Patients Aged ≥ 80 Years with Diffuse Large B-Cell Lymphoma: A Retrospective, Propensity Score-Matched Analysis Stratified by Simplified Frailty Score.

Shuku Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.